| 1 |
33707115 | Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways. | 2021 Apr |
5 |
| 2 |
32272431 | Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways. | 2020 Jun |
2 |
| 3 |
32473224 | Shikonin relieves osteoporosis of ovariectomized mice by inhibiting RANKL-induced NF-κB and NFAT pathways. | 2020 Sep 1 |
2 |
| 4 |
32952636 | Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway. | 2020 Nov |
1 |
| 5 |
24447680 | Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-κB signaling pathways. | 2014 Mar |
1 |
| 6 |
23201088 | Shikonin ameliorates cerulein-induced acute pancreatitis in mice. | 2013 Jan 30 |
1 |
| 7 |
20423347 | Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus. | 2010 May |
1 |